buprenorphine 8 mg
1 INDICATIONS AND USAGE Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contain buprenorphine, a partial opioid agonist, and are indicated for the treatment of opioid dependence and are preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
rhodes pharmaceuticals l.p.
ROUND WHITE RP b8
RP b8 ROUND WHITE
Related Pills
buprenorphine 8 mg
rhodes pharmaceuticals l.p.
buprenorphine 2 mg
rhodes pharmaceuticals l.p.
buprenorphine 8 mg
rhodes pharmaceuticals l.p.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
BUPRENORPHINE Sublingual Tablets are available in the following strengths: 2 mg – white to off-white, round flat-faced beveled edged tablet debossed with "RP" on one side and "b2" on the other side (content expressed in terms of free base, equivalent to 2.16 mg
BUPRENORPHINE hydrochloride USP). NDC 42858-501-03 30 tablets per bottle 8 mg – white to off-white, round flat-faced beveled edged tablet debossed with "RP" on one side and "b8" on the other side (content expressed in terms of free base, equivalent to 8.64 mg
BUPRENORPHINE hydrochloride USP). NDC 42858-502-03 30 tablets per bottle Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store
BUPRENORPHINE Sublingual Tablets securely and dispose of properly [see Patient Counseling Information (17) ].
More pills like ROUND RP b8